| Jul 25 |
Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
|
| Jul 15 |
Enveric stock climbs 7% on deal for radiation dermatitis drug
|
| Jul 15 |
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
|
| Jul 10 |
Enveric Biosciences Announces Patent Granted for Drug Candidate
|
| Jul 8 |
Enveric Biosciences files $200M mixed securities shelf
|
| Jul 1 |
Is Enveric Biosciences, Inc. (NASDAQ:ENVB) Trading At A 36% Discount?
|
| Jun 25 |
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
|
| May 30 |
Enveric Biosciences to Participate in BIO International Convention 2024
|
